Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Clinical Infectious Diseases November 1, 2014 V.59 N.9 P.1203-1207
Gregory M. Lucas1, Michael J. Ross2, Peter G. Stock3, Michael G. Shlipak4, Christina M. Wyatt2, Samir K. Gupta5, Mohamed G. Atta1, Kara K. Wools-Kaloustian5, Paul A. Pham1, Leslie A. Bruggeman6, Jeffrey L. Lennox7, Patricio E. Ray8, and Robert C. Kalayjian6
1Johns Hopkins School of Medicine, Baltimore, Maryland
2Icahn School of Medicine at Mount Sinai, New York, New York
3University of California, San Francisco
4San Francisco Veteran Affairs Medical Center, California
5Indiana University School of Medicine, Indianapolis
6MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio
7Emory University School of Medicine, Atlanta, Georgia
8Children’s National Medical Center, Washington D.C.
Correspondence: Gregory M. Lucas, MD, PhD, Department of Medicine, Johns Hopkins University, 1830 E Monument St, 4th Floor, Baltimore, MD 21287 (firstname.lastname@example.org).
It is important to realize that guidelines cannot always account for individual variation among patients.
They are not intended to supplant physician judgment with respect to particular patients or special clinical situations.
IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient’s individual circumstances.
Co-ordinating the clinical management of imported human cases suspected of being infected with a highly pathogenic virus such as Ebola Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons